Head-to-Head

ABBVIE INC. vs. Abbott Laboratories

ABBV

ABBVIE INC.

$264.47 +0.17%

VS ABT

Abbott Laboratories

$102.83 +0.58%

Abbott Laboratories (ABT) comes out ahead, leading on 6 of 11 compared factors.

Size & Scale

ABBVABT
Market Cap $466.55 billion $176.90 billion
Revenue (TTM) $64.39 billion $46.59 billion
Net Income (TTM) $6.32 billion $5.42 billion

ABBV leads on 3 of 3 size & scale factors.

Valuation

ABBVABT
P/E Ratio 74.71 33.28
Price / Book -79.24 3.42
Price / Sales 7.25 3.80

ABT leads on 2 of 3 valuation factors.

Profitability

ABBVABT
Net Margin 9.81% 11.65%
Return on Equity -107.29% 10.48%

ABT leads on 2 of 2 profitability factors.

Dividend

ABBVABT
Dividend Yield 2.62% 2.45%
Payout Ratio 195.48 81.55

ABBV and ABT split the dividend factors evenly.

Risk & Sentiment

ABBVABT
Short Interest 0.85% 0.57%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABBV overview, ABBV financials, ABT overview, ABT financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.